SMTL ID : 5iu7.1

Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with compound 12c at 1.9A resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x NA: SODIUM ION(Non-functional Binders)

NA.1: 3 residues within 4Å: Chain A: D.61, S.100, N.385 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.100, A:S.100 Water bridges: A:D.61

1 x 6DY: 2-(furan-2-yl)-N~5~-[2-(4-phenylpiperidin-1-yl)ethyl][1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine(Non-covalent)

6DY.2: 14 residues within 4Å: Chain A: L.94, F.177, E.178, M.186, W.351, L.354, H.355, N.358, H.369, A.370, L.372, M.375, Y.376, I.379 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.94, A:W.351, A:L.354, A:H.369, A:L.372 Hydrogen bonds: A:N.358, A:N.358 Water bridges: A:F.177 Salt bridges: A:E.178, A:E.178 pi-Stacking: A:F.177, A:F.177, A:H.369

4 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 6 residues within 4Å: Chain A: H.84, G.85, F.88 Ligands: CLR.4, OLA.22, OLB.29 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:H.84, A:F.88 Water bridges: A:H.84 CLR.4: 8 residues within 4Å: Chain A: F.71, A.81, A.82, G.85, F.88, I.89 Ligands: CLR.3, OLB.28 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.71, A:F.71, A:F.88, A:I.89, A:I.89 Hydrogen bonds: A:A.82 Water bridges: A:Q.172 CLR.5: 11 residues within 4Å: Chain A: L.349, L.352, P.353, I.356, I.357, F.360, C.367, S.368, A.370, L.374 Ligands: OLA.8 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.349, A:L.352, A:P.353, A:I.356, A:I.357, A:F.360, A:L.374 Hydrogen bonds: A:S.368 CLR.6: 9 residues within 4Å: Chain A: L.196, L.352, I.356, C.359, F.360, F.363, C.364 Ligands: OLA.23, OLB.31 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.196, A:L.352, A:I.356, A:F.360, A:F.360, A:F.360, A:F.363

18 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)

OLA.7: 7 residues within 4Å: Chain A: I.73, T.74, T.77, F.79 Ligands: OLA.12, OLB.27, OLB.28 Ligand excluded by PLIP OLA.8: 4 residues within 4Å: Chain A: P.371, W.373, L.377 Ligands: CLR.5 Ligand excluded by PLIP OLA.9: 4 residues within 4Å: Chain A: F.102, I.109, I.133, C.137 Ligand excluded by PLIP OLA.10: 8 residues within 4Å: Chain A: G.14, S.15, Y.18, V.21, L.372, Y.376, V.380 Ligands: OLA.19 Ligand excluded by PLIP OLA.11: 5 residues within 4Å: Chain A: I.136, L.140, A.143 Ligands: OLA.16, OLC.32 Ligand excluded by PLIP OLA.12: 3 residues within 4Å: Ligands: OLA.7, OLB.26, OLB.27 Ligand excluded by PLIP OLA.13: 6 residues within 4Å: Chain A: L.28, L.31, G.32, L.35, W.38, F.391 Ligand excluded by PLIP OLA.14: 1 residues within 4Å: Chain A: W.373 Ligand excluded by PLIP OLA.15: 6 residues within 4Å: Chain A: I.134, A.135, W.138, F.142 Ligands: OLA.22, OLB.29 Ligand excluded by PLIP OLA.16: 5 residues within 4Å: Chain A: R.129, G.132, I.136, V.139 Ligands: OLA.11 Ligand excluded by PLIP OLA.17: 2 residues within 4Å: Chain A: G.345, L.346 Ligand excluded by PLIP OLA.18: 4 residues within 4Å: Chain A: C.37, W.38, W.41 Ligands: OLB.30 Ligand excluded by PLIP OLA.19: 8 residues within 4Å: Chain A: A.24, I.25, T.384, V.387, V.388, F.391 Ligands: OLA.10, OLA.24 Ligand excluded by PLIP OLA.20: 5 residues within 4Å: Chain A: S.16, I.19, T.20, L.23 Ligands: OLB.26 Ligand excluded by PLIP OLA.21: 3 residues within 4Å: Chain A: G.204, L.207, R.208 Ligand excluded by PLIP OLA.22: 6 residues within 4Å: Chain A: A.143, M.149, L.150 Ligands: CLR.3, OLA.15, OLC.32 Ligand excluded by PLIP OLA.23: 8 residues within 4Å: Chain A: L.196, L.203, Y.206, L.207, A.341, A.344, A.348 Ligands: CLR.6 Ligand excluded by PLIP OLA.24: 2 residues within 4Å: Chain A: I.392 Ligands: OLA.19 Ligand excluded by PLIP

7 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)

OLB.25: 5 residues within 4Å: Chain A: Y.188, F.192, F.362, F.363 Ligands: OLB.31 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.192 OLB.26: 9 residues within 4Å: Chain A: P.11, I.12, S.15, I.19, L.23, S.76, T.77 Ligands: OLA.12, OLA.20 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.19, A:L.23, A:T.77 Hydrogen bonds: A:S.15 OLB.27: 3 residues within 4Å: Ligands: OLA.7, OLA.12, OLB.28 No protein-ligand interaction detected (PLIP) OLB.28: 11 residues within 4Å: Chain A: V.66, L.67, P.70, F.71, T.74, F.79, C.80, Q.172 Ligands: CLR.4, OLA.7, OLB.27 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.67, A:P.70, A:F.71, A:T.74, A:F.79 Hydrogen bonds: A:C.80, A:Q.172 OLB.29: 14 residues within 4Å: Chain A: Y.52, S.56, A.59, L.63, L.67, G.127, T.128, A.131, I.134, W.138, F.142 Ligands: CLR.3, OLA.15, OLB.30 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.59, A:L.63, A:I.134, A:W.138, A:W.138, A:F.142 OLB.30: 9 residues within 4Å: Chain A: C.37, V.40, W.41, Q.47, Y.52, V.55, A.59 Ligands: OLA.18, OLB.29 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:V.55 Hydrogen bonds: A:Y.52 OLB.31: 4 residues within 4Å: Chain A: F.192, F.363 Ligands: CLR.6, OLB.25 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.192, A:F.363 Hydrogen bonds: A:D.366

1 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.32: 8 residues within 4Å: Chain A: H.84, A.143, M.149, L.150, G.151, N.153 Ligands: OLA.11, OLA.22 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:A.143 Hydrogen bonds: A:H.84, A:N.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Segala, E. et al., Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. J.Med.Chem. (2016)

Release Date

2016-06-29

Peptides

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a

Related Entries With Identical Sequence